Ethical issues related to study design for trials on therapeutics for Ebola Virus Disease: WHO Ethics Working Group meeting 20-21 October, summary of discussion
Author(s)
World Health OrganizationKeywords
Hemorrhagic Fever, EbolaEbola Vaccines
Drug Approval
Ebolavirus
Disease Outbreaks
Africa, Western
Clinical Trials as Topic
Meeting Abstracts
Ethics
drug therapy
Full record
Show full item recordOnline Access
http://www.who.int/iris/handle/10665/137509Date
2014-11-05Type
Technical documentsIdentifier
oai:apps.who.int:10665/137509WHO/HIS/KER/GHE/14.2
http://www.who.int/iris/handle/10665/137509